SERVIER

Pharmaceuticals, namely, pharmaceutical preparations for the treatment of [ cardiovascular diseases, pharmaceutical preparations for preventing and treating ]disorders of the central nervous system,[ cytostatic pharmaceutical preparations for use in the treatment of ] *and * cancer, pharmaceutical preparations for preventing and treating metabolism disorders [, pharmaceutical preparations for the treatment and prevention of obesity, pharmaceutical preparations for the treatment and prevention of diabetes, pharmaceutical preparations for blood and blood forming organs for blood clotting aid, pharmaceutical preparations for the treatment and prevention of disorders of the respiratory system, pharmaceutical preparations for the treatment and prevention of disorders of the musculo-skeletal system, pharmaceutical preparations for the treatment and prevention of disorders of the genitourinary system, pharmaceutical preparations in the nature of anti-infectives, pharmaceutical preparations for the treatment and prevention of disorders of the ophtalmological system ]